Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 434 Issue 7030, 10 March 2005

Editorial

  • Across the developing world, seriously ill patients can't be sure whether they're purchasing life-saving medicines or worthless dummy pills. This scandal demands a stronger response from aid donors, governments and the drugs industry.

    Editorial

    Advertisement

  • The breakdown of an old contract threatens to leave a great national laboratory gravely weakened.

    Editorial
Top of page ⤴

News

Top of page ⤴

News in Brief

Top of page ⤴

News Feature

  • Across the developing world, people are dying after being peddled fake pharmaceuticals. Peter Aldhous reports from southeast Asia, where scientists, doctors and regulators battle against organized crime.

    • Peter Aldhous
    News Feature
  • Dora Akunyili has spent the past four years facing down corruption and tackling Nigeria's rampant problems with fake drugs. This crusade has been phenomenally successful, but has placed Akunyili's life in danger. Peter Aldhous caught up with her on a recent trip to the United States.

    • Peter Aldhous
    News Feature
Top of page ⤴

Correspondence

Top of page ⤴

Books & Arts

  • The artist Joseph Beuys tried to lead his followers into a promised land of transformative imagination.

    • Martin Kemp
    Books & Arts
Top of page ⤴

Physics Detective

Top of page ⤴

Essay

  • Human parthenotes: an ethical source of stem cells for therapies?

    • Ann A. Kiessling
    Essay
Top of page ⤴

News & Views

  • A 62-million-year cycle in biodiversity emerges from scrutiny of a marine-fossil database, but its causes remain mysterious. Thus, this discovery is likely to provoke a flurry of theoretical speculation.

    • James W. Kirchner
    • Anne Weil
    News & Views
  • Is there an upper limit to the mass of a star? The answer to this long-standing question seems to be yes — and it has important consequences for our understanding of the evolution of galaxies.

    • Pavel Kroupa
    News & Views
  • Variations in the control of a phenomenon known as parental imprinting influence the likelihood of tumour development. These new findings may tie in with an earlier concept of ‘two-phase’ carcinogenesis.

    • George Klein
    News & Views
  • Organic semiconducting polymers are promising electronic materials, but for full versatility they need to conduct negative as well as positive charge. A step towards that goal has now been taken.

    • Ananth Dodabalapur
    News & Views
  • The identity of the sperm molecules that are involved in fusion with an egg's membrane has eluded biologists. Will Izumo, a protein named after the Japanese shrine to marriage, bring harmony to the field?

    • Richard Schultz
    • Carmen Williams
    News & Views
  • The likely origin of Pluto and its satellite Charon, like the Earth and Moon, is an impact between two planet-sized bodies. Refined simulations show that there may be two distinct modes for the birth of such twins.

    • Jay Melosh
    News & Views
  • Claims that 3.8-billion-year-old rocks from Greenland contain carbonaceous remnants of very early life have been the subject of argument for several years. The latest analyses look like settling matters.

    • Stephen Moorbath
    News & Views
Top of page ⤴

Research Highlights

Top of page ⤴

Brief Communication

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Prospects

Top of page ⤴

Careers and Recruitment

  • The addition of molecular biology to the existing range of imaging technologies is creating opportunities for scientists of many disciplines. Paul Smaglik lines up the pieces.

    • Paul Smaglik
    Careers and Recruitment
Top of page ⤴

Futures

Top of page ⤴
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links